Two Sigma Advisers LP bought a new position in shares of Rentokil Initial plc (NYSE:RTO - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 39,400 shares of the company's stock, valued at approximately $998,000.
Several other institutional investors and hedge funds have also made changes to their positions in RTO. Cape Investment Advisory Inc. raised its stake in shares of Rentokil Initial by 65.2% during the fourth quarter. Cape Investment Advisory Inc. now owns 1,505 shares of the company's stock valued at $38,000 after acquiring an additional 594 shares in the last quarter. CENTRAL TRUST Co raised its stake in shares of Rentokil Initial by 15,208.3% during the fourth quarter. CENTRAL TRUST Co now owns 1,837 shares of the company's stock valued at $47,000 after acquiring an additional 1,825 shares in the last quarter. Smartleaf Asset Management LLC raised its position in Rentokil Initial by 486.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 1,942 shares of the company's stock valued at $49,000 after purchasing an additional 1,611 shares in the last quarter. Cromwell Holdings LLC bought a new stake in Rentokil Initial during the 4th quarter valued at $59,000. Finally, Blue Trust Inc. raised its position in Rentokil Initial by 140.4% during the 4th quarter. Blue Trust Inc. now owns 2,402 shares of the company's stock valued at $60,000 after purchasing an additional 1,403 shares in the last quarter. 9.91% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
RTO has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating on shares of Rentokil Initial in a research report on Friday, March 7th. Sanford C. Bernstein downgraded Rentokil Initial from a "market perform" rating to an "underperform" rating in a report on Thursday, May 15th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, Rentokil Initial has a consensus rating of "Moderate Buy".
Check Out Our Latest Analysis on Rentokil Initial
Rentokil Initial Stock Up 0.7%
NYSE:RTO traded up $0.17 during trading hours on Wednesday, reaching $23.79. The company's stock had a trading volume of 262,553 shares, compared to its average volume of 783,970. The company has a market capitalization of $12.01 billion, a P/E ratio of 15.75, a price-to-earnings-growth ratio of 7.95 and a beta of 0.96. Rentokil Initial plc has a 12 month low of $19.60 and a 12 month high of $34.07. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.96 and a current ratio of 1.04. The stock has a 50 day moving average price of $22.89 and a two-hundred day moving average price of $24.12.
Rentokil Initial Announces Dividend
The company also recently declared a semi-annual dividend, which was paid on Thursday, May 15th. Shareholders of record on Friday, April 4th were given a dividend of $0.3825 per share. This represents a dividend yield of 2.4%. The ex-dividend date of this dividend was Friday, April 4th. Rentokil Initial's payout ratio is 45.03%.
About Rentokil Initial
(
Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Further Reading

Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.